Henan Cancer Hospital
2 clinical trials · 2 recruiting · OTHER_GOV
Trials by Henan Cancer Hospital
RECRUITINGPhase 3NCT05063136
Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast Cancer
Breast cancer (BC) is one of most prevalent malignant tumors in the world. According to the 2020 edition of the global cancer statistics report, the incidence rate of BC has...
Sponsor: Henan Cancer HospitalEnrolling: 19791 location
Breast Cancer
RECRUITINGPhase 3NCT05495152
Adjuvant Sintilimab for Locally Advanced Esophageal Squamous Cell Carcinoma
No adjuvant treatment has been established for patients who remain at high risk for recurrence after neoadjuvant chemotherapy plus surgery and incidental pathologic lymph node...
Sponsor: Henan Cancer HospitalEnrolling: 2192 locations
Esophageal Squamous Cell Carcinoma